MARKET

DBVT

DBVT

Dbv Technologies S A
NASDAQ
16.00
-0.59
-3.56%
Pre Market: 16.11 +0.11 +0.69% 06:16 06/09 EDT
OPEN
16.75
PREV CLOSE
16.59
HIGH
16.78
LOW
15.84
VOLUME
1.32K
TURNOVER
11.06K
52 WEEK HIGH
26.19
52 WEEK LOW
8.48
MARKET CAP
947.34M
P/E (TTM)
-3.0395
1D
5D
1M
3M
1Y
5Y
1D
DBV Technologies to present new Viaskin Peanut Patch data at EAACI Congress 2026
PUBT · 18h ago
DBV Technologies To Present New Data From VITESSE Study And Preview Recently Initiated THRIVE Study At EAACI Congress 2026
Benzinga · 18h ago
DBV Technologies launches Phase 2 THRIVE trial of Viaskin Peanut Patch in peanut-allergic infants 6-12 months
PUBT · 18h ago
Weekly Report: what happened at DBVT last week (0601-0605)?
Weekly Report · 1d ago
DBV Technologies to Participate in the Goldman Sachs 47th Annual Global Healthcare Conference
Barchart · 3d ago
DBV Technologies says JPMorgan Chase holds 10.03% stake
PUBT · 4d ago
DBV Technologies publishes AGM presentation for June 3, 2026 meeting
PUBT · 5d ago
DBV Technologies Shareholders Approve Governance and Capital Measures
TipRanks · 5d ago
More
About DBVT
DBV Technologies SA is a France-based clinical-stage biopharmaceutical company focused on changing the field of immunotherapy by developing a technology platform called Vaskin. The Company's therapeutic approach is based on epicutaneous immunotherapy, or EPIT, its proprietary method of delivering biologically active compounds to the immune system through intact skin using Viaskin. It dedicates its technology to treat patients, including infants and children, suffering from severe food allergies, for whom safety is paramount, since the introduction of the offending allergen into their bloodstream can cause severe or life-threatening allergic reactions, such as anaphylactic shock. The Company's product portfolio for allergy treatments consists of Viaskin Peanut, Viaskin Milk and Viaskin Egg. The Company operates one subsidiary DBV Technologies Inc. in the United States.

Webull offers DBV Technologies SA - ADR stock information, including NASDAQ: DBVT real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, DBVT stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading DBVT stock methods without spending real money on the virtual paper trading platform.